RT @ericdeinmd: How is a biosimilar approved? Comparative effectiveness study for the reason that the medication was ini
Tweet Content
How is a biosimilar approved?
Comparative effectiveness study for the reason that the medication was initial approved required, not for other indications
Jonathan Kay shows ex of ETN-ykro vs reference ETN in RA
Non-inferior in immunogenicity, safety, efficacy
@RheumNow #RNL2023 https://t.co/OOHie9Qr5t
Show on Archive Page
On
Display in Search Results
On
PDQ
Off